RAIN - Rain Therapeutics Inc. (RAIN) CEO Avanish Vellanki on Q2 2021 Results - Earnings Call Transcript
Rain Therapeutics, Inc. (RAIN) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET Company Participants Glenn Garmont - LifeSci Advisors, Investor Relations Avanish Vellanki - Chief Executive Officer Richard Bryce - Chief Medical Officer Bob Doebele - Chief Scientific Officer Nelson Cabatuan - Senior Vice President, Finance & Administration Conference Call Participants Graig Suvannavejh - Goldman Sachs Yigal Nochomovitz - Citi Joe Catanzaro - Piper Sandler Charles Zhu - Guggenheim Securities Presentation Operator Good afternoon and welcome to the Rain Therapeutics' Second Quarter 2021 Financial Results and Highlights of Recent Progress Conference Call. My name is Reese, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] I will now turn the call over to Glenn Garmont with LifeSci Advisors. Glenn, you may begin. Glenn Garmont [technical difficulty] Senior Vice
For further details see:
Rain Therapeutics, Inc. (RAIN) CEO Avanish Vellanki on Q2 2021 Results - Earnings Call Transcript